Key Takeaways Expansion in biologics, digitalization, and new manufacturing assets enhances revenue growth, margin improvement, and market share in both Indian and US markets. Deep industry partnerships, outsourcing trends, and regulatory credibility ensure sustained growth momentum, robust client wins, and long-term business stability.Read more
